The Impact of Cycle Threshold Value in Influencing the Performance of COVID-19 Antigen

Author:

Febrian Rivaldi,Kumalawati July,Putri Nina Dwi,Luciana Linny,Kekalih Aria

Abstract

COVID-19 antigen is an alternative test for detecting SARS-CoV-2 infection. Viral load represented by the Cycle Threshold (CT) in the Real-Time Reverse Transcriptase Polymerase Chain Reaction (rRT-PCR) affects the diagnostic performance of the test. Higher CT values result in reduced sensitivity of the SARS-CoV-2 antigen. The main objective of this study was to determine the highest CT value in rRT-PCR that still yielded reactive results in the COVID-19 antigen test. This cross-sectional study was conducted at the Fever Outpatient Clinic in Dr. Cipto Mangunkusumo Hospital from July 2020 to June 2021. Two hundred and thirty-five naso-oropharyngeal swabs were taken from patients with confirmed and suspected COVID-19 diagnoses. About 24.7% of subjects were tested positive. The median highest CT value giving reactive COVID-19 antigen results was 28.22 (13.33-39.16), while the median CT value for non-reactive antigen results was 34.45 (26.08-39.65). At a CT value < 40, the COVID-19 antigen test demonstrated 63.8% sensitivity, 99.4% specificity, 89.3% Negative Predictive Value (NPV), and 97.4% Positive Predictive Value (PPV). At the CT value < 25, the test showed 92.3% sensitivity, 99.4% specificity, 99.4% NPV, 92.3% PPV, 163.4 LR+, and 0.1 LR-. The identified cut-off point for the CT value was 29.82, with a sensitivity of 64.9% and specificity of 81%. In conclusion, COVID-19 antigen is a valuable test for screening patients with symptoms of SARS-CoV-2 infection. Understanding the influence of cycle threshold can enhance the interpretation and reliability of the antigen test.

Publisher

PDS Patklin

Reference12 articles.

1. World Health Organization. Global update on Coronavirus disease. [Internet]. 2021. Available from: https://www.who.int/indonesia/news/novel-coronavirus (accessed April 17, 2021).

2. World Health Organization. Laboratory testing for Coronavirus Disease 2019 (COVID-19) in suspected human cases [Internet]. 2021. Available from: https://www.who.int/publications-detail/laboratory-testing-for-2019-novelcoronavirus-in-suspected-human-cases-20200117 (accessed April 17, 2021).

3. Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection (Review). Cochrane Database of Systematic Reviews 2020; 8: CD013705.

4. Testing for SARS-CoV-2 (COVID-19): A systematic review and clinical guide to molecular and serological in-vitro diagnostic assays;La Marca;Reprod Biomed Online,2020

5. Menteri Kesehatan Republik Indonesia. Panduan pelaksanaan pemeriksaan, pelacakan, karantina, dan isolasi dalam rangka percepatan pencegahan dan pengedalian Coronavirus Disease 2019 (COVID-19) [Internet]. 2021. Available from: https://covid19.go.id/storage/app/media/Regulasi/2021/Mei/kmk-no-hk0107-menkes-4641-2021-ttg-panduan-pelaksanaan-pemeriksaan-pelacakan-karantina-isolasi-dalam-pencegahan-covid-19-sign.pdf (accessed April 17, 2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3